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Abstract 
Background: Diabetes mellitus (DM) is recognized as one of the major non-communicable diseases in Ethiopia. 
However, the overall features associated with DM are not well documented and updated regularly.  
Objective: This paper is focused on reviewing and updating the literature on diabetes mellitus, its features, 
complications, and associated communicable diseases in Ethiopia.   
Methods: The researcher has carried out a systematic review of research papers published from 1970 to 2013 on DM 
and associated diseases in Ethiopia.   
Results and discussion: According to International Diabetes Federation, IDF 2012 report, the prevalence of DM in 
Ethiopia stands at 3.32 %. However, DM prevalence of as high as 8% has been reported in 2013 on HIV/AIDS 
patients taking HAART, in Ethiopia. Major DM related complications include: hypertension, neuropathy, and DM foot 
disease. The prevalence of these diseases has risen from 12.1%, 27.7%, and 1.7% in 1976-1997, to 34.1%, 29.5%, and 
4.6 % respectively in 2005 to 2009. On the other hand, retinopathy prevalence looks stable at around 33.3% for long 
period. On the other hand, the prevalence of infectious diseases such as: UTI, HCV and tuberculosis that is associated 
with DM reaches up to 17.8%, 9.9%, and 8.5 % respectively. But, no study has been conducted confirming whether 
DM increases infectious diseases occurrences or vice versa.  
Conclusion: DM occurrences and complications have been increasing throughout the country. Thus, the Ministry of 
Health and other stakeholders need to join hands to prevent and control the prevalence and sufferings associated with 
DM. Especially, more emphasis should be given to raise the awareness of the general public about the disease.  
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Background 
DM is one of the most common non-communicable 
diseases, affecting the health of a significant number of 
the population throughout the world (1). The major 
characteristic feature of DM is occurrence of fasting 
blood glucose value greater than 126mg/dl (2). The 
global prevalence is projected to rise from 171 million in 
the year 2000 to 366 million in 2030 (3). In Africa, the 
prevalence of DM is increasing and the magnitude of the 
disease is progressing (4). In sub-Saharan Africa, over 12 
million people are expected to have DM, and 330,000 of 
these people will die from DM related complications (5). 
In Ethiopia, according to WHO estimation, the number of 
diabetics cases in the year 2000 was 800,000 and this 
number is expected to increase to 1.8 million by the year 
2030 (6). 
 
In Ethiopia, although DM is recognized as one of the 
major non-communicable diseases, the exact prevalence, 
progress, and associated complications are not well 
documented and updated regularly. Therefore, this paper 
is targeted at analyzing the progress of DM in Ethiopia 
and DM associated complications and infectious diseases 
seen on DM patients. 
 
Methods 
This is a systematic review of electronic journals from 
pub med, Google, and other search engines from 1970s to
2013. The review was mainly focused on the prevalence 
of DM, occurrence of DM with other communicable 
diseases and DM associated micro and macro vascular 
complications. Of the total reviewed journals, the 
researcher took inputs from 38 articles and presented his 
findings as follows. 
 
Results  
Prevalence of DM in Ethiopia 
In Ethiopia, although a nationwide surveillance on 
occurrence of DM has not been made, IDF 2012 report 
indicated an estimated DM prevalence of 3.32 % (7). 
However, DM prevalence of as high as 8% has been 
reported in 2013 on HIV/AIDS patients taking HAART 
(8). On the other hand, a study conducted in Jimma 
reported 15% Impaired Glucose Tolerances, IGT 
prevalence (9). 
 
The distribution of DM between male and female 
patients, as shown in Table 1, shows variations in 
different studies. Some studies indicated proportional 
distribution (10-12), where as in others the proportion 
seems more inclined to either one of the sexes (13-15). 
These differences, however, might be explained by the 
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Table 1: Female to male percentage distribution of DM cases on selected studies in Ethiopia 
Province Year of study Sample size Female/ Male % Reference  
Addis Ababa and 
central Ethiopia  
1976-1983 849 50.2 %Female; 49.8% Male [10] 
Addis Ababa 1996-1997 283 48.4% Female; 51.6% Male [11] 
Gondar, Northwest 
Ethiopia 
2000-2009 1553 42.5% Female; 57.5 Male [12] 
Addis Ababa 2005 – 2009 724 48.3% Females; 51.7% Male [13] 
Addis Ababa 2005 229 63.8% Female; 36.2% Male [14] 
Jimma, South west of 
Ethiopia 
2008 305 37% Female; 63% Male [15] 
 
Table 2: Distribution of DM associated complications on selected studies conducted in Ethiopia 

















849 12.1 33.3 27.7 27.7 - [10] 
Addis Ababa 1996-
1997 
283 18.4 31.4 35.2 23.3 1.7 [11] 
Addis Ababa 2005 – 
2009 
724 34 15.5 12.4 32 - [13] 
Addis Ababa 2005 229 34.1 33.2 10.5 21.0 - [14] 
Jimma 2008 305 24.9 33.8 29.5 15.7 4.6 [15] 
 
Regarding the progress and distribution of DM in 
Ethiopia, a ten year retrospective study on the spread of 
DM conducted in Gondar Hospital (Northern Ethiopia) 
indicated that both Type 1 DM (T1DM) and Type 2 DM 
(T2DM), cases increased by 125% on average (16). 
T1DM was mostly diagnosed at late age, for example in  
Gondar, average 30.4+/- 11.6 years old, which is 
different from what is known in western countries (17, 
18). Moreover, studies indicated that T1DM is more 
common in rural parts of the county (18), whereas 
T2DMis more prevalent in urban areas and big cities of 
the country (15). On the other hand, the prevalence 
gestational diabetes mellitus (GDM0 in Ethiopia, shows 
big ranges, from 3.7% in Tigray, Northern Ethiopia (19) 
to 0.4% in Addis Ababa (20). The variation in GDM may 
be associated with socio economic, availability of health 
facilities, study subject selection, and study period 
differences between two study places. But to see the 
actual picture of GDM in the country, more studies need 
to be undertaken. 
 
Diabetes and Associated Complications in Ethiopia: 
DM is usually characterized by complications that occur 
in the natural course of the disease progression. DM 
associated complications and admissions in Addis Ababa, 
at St. Paul and Black Lion Specialized Hospitals show 
that the prevalence has increased from 7.1% in 2005 to  
34.1% in 2009 (13). Diabetes keto-acidosis (DKA), one 
of the acute complications, is most commonly seen on 
T1DM patients (15, 21), whereas other chronic 
complications of DM including retinopathy, neuropathy, 
and foot diseases are mostly seen in T2DM patients. 
 
Table 3: Prevalence of infectious diseases in DM on selected studies conducted in Ethiopia 
Study site and year Sample size Infectious diseases in DM and prevalence 
percentage (%) 
Ref.no. 
Addis Ababa [2009] 413 Urinary tract infections(UTI)……10.9 % [23] 
Gondar [2010] 422 Urinary tract infections(UTI)……17.8% [24] 
Gondar [2010] 422 Candidacies…………………  …..8.3 % [27] 
Addis Ababa [1989-1996] 1352 Mycobacterium tuberculosis …..5.8% [28] 
Jimma [2008] 305 Mycobacterium tuberculosis …..5.6 % [15] 
Gondar [2011-1012] 199 among Tb.DM Mycobacterium tuberculosis …..8.5 % [26] 
Desse [2012] 225 among DM...Tb Mycobacterium tuberculosis …..6.2 % [29] 
Jimma  [2010] 604 Hepatitis C virus………………9.9 % [25] 










As shown in table 2, hypertension increased from 12.1% 
in 1980s (10) to more than 34 % in 2009 (13, 14); 
whereas eye disease prevalence just like that of 1980s 
(10), in 2009 reports indicated prevalence still as high as 
above 33% (15). In addition, other DM associated 
complications including neuropathy and renal diseases 
prevalence rate in recent years has reached up to 29.5 % 
and 32% respectively (13, 15). 
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Impotency, the other major health problem on diabetes 
patients, was assessed on 292 T1DM and T2DM men at 
Black Lion Specialized Hospital, and almost 49 % had 
the problem, whereas similar study in Jimma, indicated 
that of the studied 305 DM patients, almost 7% had 
impotency. The problem was more observed on T2DM 
patients and the compliance of the problem increases 
with the increase in the duration of DM (15, 22). 
 
The reported difference might be associate with cultural 
difference to discuss about the issues as well awareness 
about association of DM and Impotency by the patients 
in the two study sites. 
 
Diabetes with other Communicable Diseases in 
Ethiopia:   
DM exposes to other communicable diseases or else the 
reverse is supposed to happen in many researches. 
Studies conducted in Ethiopia, as shown in table 3, 
indicated that most commonly observed infectious 
diseases on Ethiopian DM patients include: Urinary Tract 
Infection (UTI), Hepatitis C Virus (HCV) infections, 
Mycobacterium tuberculosis, and Candidacies infections. 
Prevalence of these diseases reaches up to 17.8% (24), 
9.9% (25), 8.5% (26), and 8.3% (27) respectively. As 
indicated by different researches, the occurrence of 
communicable diseases also increases during progress of 
DM in Ethiopia. 
 
 
Figure1: Distribution of T1DM and T2DM on selected studies conducted in Ethiopia 
 
Discussion 
The actual prevalence of DM in Ethiopia could be as 
high as 8% (8) as suggested by some institution-based 
studies, aside from what is projected by IDF in 2012 as 
3.32% (7) in 2012. Although strong nationwide 
surveillances have not been conducted, the DM 
expansion rate is growing in alarming rate, and so are 
associated morbidity and mortality rates. 
 
The distribution of T1DM, and T2DM in Ethiopia, shows 
regional variations, T1DM is more dominant in rural 
parts, whereas T2DM is more common in small and big 
cities of the country (8, 15). Moreover, the occurrence of 
T2DM in the country looks to progress so fast and going 
to become the leading cause of morbidity and mortality 
among non-communicable diseases (13, 16). This is 
largely associated with an increase in the income of the 
country, and gradual life style shift of the people into” 
modern” life. 
 
On the other hand, the reported prevalence of GDM 
greatly varies in the country (range from 3.7 to 0.4%) 
(19, 20). The reason of which is not clear but indicated, 
up to the knowledge of the reviewer, scarcity of research 
on this type of DM, or regional differences in the quality 
of mother care during study periods.  GDM is one of the 
serious health problems on pregnant mothers, and if not 
diagnosed and controlled on time, could result in serious 
morbidity and mortality on the mother and the fetus.  
 
Diabetes associated complications, including keto-
acidosis DKA, hypertension, retinopathy, neuropathy, 
nephropathy, and DM foot diseases are now-a-days very 
common in most hospitals and other health institutions in 
Ethiopia (13). Although there are discrepancies among 
studies on the prevalence of complications among DM 
patients, the overall picture shows that DM complications 
in Ethiopia are rapidly increasing during the last decades. 
One of the major possible reasons for the expansions of 
the complications is diagnosis of the DM mostly relay 
only on blood glucose determinations. If other diagnostic 
approaches, such as Hemoglobin A1C determinations, 
Serum insulin, and C-peptide concentration 
determination would be applied, the complications may 
be diagnosed at early stages (14, 31) and worsening 
prevented. In addition poor understanding about the 
nature of DM by patients, and/or insufficient information 
by diabetic clinics or nearby health institutions may 
prevent that patents pursue a serious treatment follow up 
after diagnosis of DM. 
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Infectious diseases are important causes of morbidity and 
mortality among diabetes patients. For example, the 
prevalence of high blood sugar value, among 199 
consecutive active M. tuberculosis patients was 8.5% in 
Gondor, and high DM prevalence was shown especially 
in those who have TB-HIV/AIDS co-infected patients 
(26).  As other related studies indicate, occurrence of M. 
tuberculosis infection in DM patients, makes treatment 
outcome for M. tuberculosis poor, and results in the 
development of drug resistant. These will cause serious 
complications, and even shorten life span of DM patients 
(32). Therefore, including M tuberculosis diagnosis for 
DM patients may be important in Ethiopia to prevent and 
control associated problems at the early stages. 
 
The other communicable diseases such as candidiasis and 
UTI are usually higher on female DM patients. This is 
mainly due to anatomical and physiological nature of 
urinary tract and genital areas difference between male 
and females (23, 24, 27). Regular checkups of DM 
patients for bacteriuria, mainly for UTI, are so crucial for 
treatment and prevention of the development of renal 
complications. Therefore, in routine DM check-ups, 
mainly for female patients, diagnosis for UTI and 
candidacies infections should be included. 
 
Hepatitis, the other commonly seen infectious disease 
among DM patients, has got an attention as a risk factor 
mainly for T2DM in recent years (33, 34). According to a 
study conducted in Jimma, Ethiopia, there is a positive 
correlation between DM and HCV (25), where as that of 
the study done in Woldyia, Northern Ethiopia, could not 
show the significant association of HBV and HCV with 
DM (30). These differences may come from either from 
the methods used by the researchers to diagnose HBV 
and HCV infections, or by chance of selection of study 
participants. But, in general, as hepatitis virus mainly 
affect the liver, the principal organ on the regulation of 
blood sugar, it is so important to obtain more consistent 
data on the association of DM and hepatitis by 
conducting large scale cohort studies.  In Addition, it 
may be important to consider diagnosing of HCV 
infected patients also for DM. 
 
In general gradual impairment of immune function on 
DM patients (35) makes them vulnerable to 
communicable diseases. Therefore, health care workers 
and other stakeholders need to redouble their efforts to 
increase the public awareness on DM pathology and 




DM is the one of commonest non-communicable disease 
responsible for a number of serious health problems and 
complications in Ethiopia. Like many other developing 
countries, in Ethiopia too, more attention is given to the 
communicable diseases, such as HIV/AIDS, tuberculosis 
and malaria. However, studies are indicating that non-
communicable diseases, such as DM are becoming major 
public health problems in the country. Hence, due 
attention should be given to DM through increasing 
public awareness on the diseases and even plan mass 
screening programs for DM. Moreover, efforts should be 
exerted to educate DM patients on how to control and 
reduce occurrences of DM associated complications. 
They should also be trained in proper diagnostic methods 
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